Valeo Pharma Inc. (VPHIF)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Jul 15, 2026

Valeo Pharma Financials Overview

Millions CAD. Fiscal year is Nov - Oct.

Revenue & Profits

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJul '24 Oct '23 Oct '22 Oct '21 Oct '20 Oct '19
Revenue
53.3853.9127.7513.567.476.58
Revenue Growth
-0.17%94.31%104.65%81.49%13.58%50.09%
Gross Profit
12.0214.588.524.141.381.4
Operating Income
-16.21-15.27-17.15-11.38-4.25-3.74
Net Income
-32.12-27.81-25.75-14.23-4.76-3.62
Earnings Per Share
-0.37-0.32-0.32-0.20-0.08-0.07
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJul '24 Oct '23 Oct '22 Oct '21 Oct '20 Oct '19
Cash & Investments
7.137.522.52.042.840.34
Total Debt
70.7365.7661.447.673.261
Net Cash (Debt)
-63.6-58.26-38.94-5.63-0.43-0.67
Net Cash Growth
------
Net Cash Per Share
-0.72-0.68-0.48-0.08-0.01-0.01

Cash Flow & CapEx

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJul '24 Oct '23 Oct '22 Oct '21 Oct '20 Oct '19
Operating Cash Flow
-3.9-15.7-28.5-12.32-5.3-2.31
Capital Expenditures
-0.12-0.48-0.36-0.9-0.06-0.03
Free Cash Flow
-4.02-16.17-28.86-13.22-5.36-2.33
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJul '24 Oct '23 Oct '22 Oct '21 Oct '20 Oct '19
Gross Margin
22.51%27.05%30.70%30.56%18.49%21.30%
Operating Margin
-30.37%-28.32%-61.80%-83.96%-56.85%-56.82%
Pretax Margin
-60.18%-51.58%-97.03%-104.99%-63.73%-54.96%
Profit Margin
-60.18%-51.58%-92.80%-104.99%-63.73%-54.96%
FCF Margin
-7.54%-30.00%-104.03%-97.49%-71.75%-35.46%

Valuation

Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingAug '26 Oct '23 Oct '22 Oct '21 Oct '20 Oct '19
PS Ratio
00.271.974.907.85-